J. Zeffren

1.1k citations
18 papers · 774 · h-index 14

Impact in

Papers in

    • Cancer Immunotherapy and Biomarkers 6
    • CAR-T cell therapy research 2
    • Immunotherapy and Immune Responses 4
    • Immune Cell Function and Interaction 3

J. Zeffren

18 papers receiving 711 citations

Peers

J. Zeffren
Comparison fields: 5 of 66
  • Dermatology 172
  • Pathology and Forensic Medicine 229
  • Immunology 267
  • Oncology 258
  • Genetics 96
Replace N T O'Connor with:
N T O'Connor United Kingdom
C Gisselbrecht France
Debra Sarasohn United States
Filiz Şen United States
Giovanna Motta Italy
Chin-Yang Li United States
Razelle Kurzrock United States
Maricer P. Escalón United States
Woo‐Ick Yang South Korea
Atto Billio Italy
J. Zeffren relative to N T O'Connor United Kingdom N T O'Connor's profile →
Citations per field
00.5×1.5×
N T O'Connor · 1×
Citations per year

Countries citing papers authored by J. Zeffren

Since Specialization
Citations

This map shows the geographic impact of J. Zeffren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Zeffren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Zeffren more than expected).

Fields of papers citing papers by J. Zeffren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Zeffren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Zeffren. The network helps show where J. Zeffren may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Zeffren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Zeffren Line = papers co-authored together J. Zeffren links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 1984205
2 1989158
3 199295
4 199057
5 196044
6 196242
7 199027
8 199123
9 199122
10 199321
11 199319
12 199114
13
Phase II trial of methyl-GAG in advanced renal cancer.
198114
14
Phase I-II trial of a 5-day continuous infusion of vinblastine sulfate.
198513
15 199110
16
Effects of prolonged tolbutamide therapy on hepatic function and serum cholesterol of adult diabetic patients.
19574
17 19573
18
Biologic therapy of cancer.
19903

About J. Zeffren

J. Zeffren is a scholar working on Oncology, Immunology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 18 papers that have together received 774 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (4 papers), Renal cell carcinoma treatment (3 papers), Immune Cell Function and Interaction (3 papers), Lymphoma Diagnosis and Treatment (3 papers), CAR-T cell therapy research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Dermatology (172 citations), Pathology and Forensic Medicine (229 citations), Immunology (267 citations), Oncology (258 citations) and Genetics (96 citations). J. Zeffren has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Steven T. Rosen, Henry H. Roenigk, Robin T. Vollmer, Elise A. Olsen, Daina Variakojis, John E. Ultmann, H. Heinemann, Nancy P. Moldawer, Jean B. deKernion and Arie S. Belldegrun. Their work appears in journals such as Journal of Immunotherapy, Cancer, Journal of Clinical Oncology, Annals of the New York Academy of Sciences and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact